PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 165 filers reported holding PUMA BIOTECHNOLOGY INC in Q3 2015. The put-call ratio across all filers is 0.14 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $227,000 | -67.9% | 1,944 | -35.2% | 0.07% | -74.5% |
| Q1 2015 | $708,000 | +6.9% | 3,000 | -14.3% | 0.26% | -16.5% |
| Q4 2014 | $662,000 | -30.6% | 3,500 | -12.5% | 0.31% | -34.7% |
| Q3 2014 | $954,000 | +261.4% | 4,000 | 0.0% | 0.48% | +161.0% |
| Q2 2014 | $264,000 | -59.1% | 4,000 | -35.5% | 0.18% | -60.6% |
| Q1 2014 | $646,000 | -37.6% | 6,200 | -38.0% | 0.46% | +168.6% |
| Q4 2013 | $1,035,000 | – | 10,000 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,300,000 | $13,338,000 | 2.17% |
| Camber Capital Management LP | 2,555,000 | $26,214,000 | 0.92% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,959,741 | $40,627,000 | 0.80% |
| Palo Alto Investors LP | 1,373,897 | $14,096,000 | 0.74% |
| Sofinnova Investments, Inc. | 629,650 | $6,460,000 | 0.38% |
| RICE HALL JAMES & ASSOCIATES, LLC | 604,937 | $6,207,000 | 0.22% |
| J. Goldman & Co LP | 238,617 | $2,448,000 | 0.12% |
| GLOBEFLEX CAPITAL L P | 55,027 | $565,000 | 0.12% |
| FRED ALGER MANAGEMENT, LLC | 3,416,003 | $35,048,000 | 0.09% |
| JUPITER ASSET MANAGEMENT LTD | 728,440 | $7,474,000 | 0.08% |